Skip to content

Nasdaq · CIK 0001641281

BOLT Bolt Biotherapeutics, Inc.

Insider trading from SEC Form 4. Last filing 22 d ago. Close $4.11 on Oct 9, 2026, +29% from the 52-week low and -42% from the high.

Last 90 days

Net insider value
-$124k
more sold than bought
Buys
2
$4,442 by 2 insiders
Sells
3
$128k by 3 insiders
Insiders on file
8
with a Form 4 at this company

Price and insider trades, last year

BOLTOct 9, 2026 · close 4.11

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Bolt Biotherapeutics, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
39WeakWilliam P. Quinn
President, CEO and CFO
buy
$2,469
637 shares
+28%-
57ModerateWilliam P. Quinn
President, CEO and CFO
sell
$58k
17,566 shares
-41%-
29WeakSarah Nemec
Senior VP, Finance and PAO
buy
$1,973
509 shares
+36%-
45ModerateSarah Nemec
Senior VP, Finance and PAO
sell
$26k
7,842 shares
-31%-
51ModerateGrant Yonehiro
Chief Operating Officer
sell
$44k
13,176 shares
-43%-
34WeakSarah Nemec
Senior VP, Finance and PAO
buy
$576
125 shares
+10%+20% from low-56% from high
44ModerateWilliam P. Quinn
President, CEO and CFO
buy
$576
125 shares
+6%+20% from low-56% from high
44ModerateWilliam P. Quinn
President, CEO and CFO
buy
$687
125 shares
+6%+10% from low-52% from high
34WeakSarah Nemec
Senior VP, Finance and PAO
buy
$687
125 shares
+15%+10% from low-52% from high
36WeakWilliam P. Quinn
President, CEO and CFO
buy
$2,835
5,000 shares
+14%-
29WeakSarah Nemec
Senior VP, Finance and PAO
buy
$2,835
5,000 shares
+44%-

Transactions

The last 100 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Jun 5, 2026Sarah Nemec
Senior VP, Finance and PAO
POpen-market purchase
Common Stock
+509$3.88$1,9731,92422 d ago
Jun 5, 2026William P. Quinn
President, CEO and CFO
POpen-market purchase
Common Stock
+637$3.88$2,4692,95022 d ago
Sep 16, 2026Grant Yonehiro
Chief Operating Officer
SOpen-market sale
Common Stock
-1,417$3.77$5,34829,02822 d ago
Sep 17, 2026Grant Yonehiro
Chief Operating Officer
SOpen-market sale
Common Stock
-4,909$3.32$16k24,11922 d ago
Sep 16, 2026Sarah Nemec
Senior VP, Finance and PAO
SOpen-market sale
Common Stock
-843$3.77$3,18124,08122 d ago
Sep 16, 2026William P. Quinn
President, CEO and CFO
SOpen-market sale
Common Stock
-1,889$3.77$7,12941,06122 d ago
Sep 17, 2026William P. Quinn
President, CEO and CFO
SOpen-market sale
Common Stock
-6,545$3.32$22k34,51622 d ago
Sep 18, 2026Grant Yonehiro
Chief Operating Officer
SOpen-market sale
Common Stock
-6,850$3.24$22k17,26922 d ago
Sep 17, 2026Sarah Nemec
Senior VP, Finance and PAO
SOpen-market sale
Common Stock
-2,922$3.32$9,69621,15922 d ago
Sep 18, 2026William P. Quinn
President, CEO and CFO
SOpen-market sale
Common Stock
-9,132$3.24$30k25,38422 d ago
Sep 18, 2026Sarah Nemec
Senior VP, Finance and PAO
SOpen-market sale
Common Stock
-4,077$3.24$13k17,08222 d ago
Jun 10, 2026Jakob Dupont
director
AGrant or award
Stock Option (Right to Buy)derivative
+5,000$0.00$05,000Jun 11, 2026
Jun 10, 2026Nicole Onetto
director
AGrant or award
Stock Option (Right to Buy)derivative
+5,000$0.00$05,000Jun 11, 2026
Jun 10, 2026Kathleen Laporte
director
AGrant or award
Stock Option (Right to Buy)derivative
+5,000$0.00$05,000Jun 11, 2026
Jun 10, 2026Laura Berner
director
AGrant or award
Stock Option (Right to Buy)derivative
+5,000$0.00$05,000Jun 11, 2026
Jun 10, 2026Brian O'Callaghan
director
AGrant or award
Stock Option (Right to Buy)derivative
+5,000$0.00$05,000Jun 11, 2026
Jan 28, 2026Grant Yonehiro
Chief Operating Officer
AGrant or award
Employee Stock Option (Right to Buy)derivative
+10,000$0.00$010,000Feb 4, 2026
Dec 5, 2025Sarah Nemec
Senior VP, Finance and PAO
POpen-market purchase
Common Stock
+125$4.61$5761,415Feb 4, 2026
Dec 5, 2025William P. Quinn
President, CEO and CFO
POpen-market purchase
Common Stock
+125$4.61$5762,313Feb 4, 2026
Jan 28, 2026Sarah Nemec
Senior VP, Finance and PAO
AGrant or award
Employee Stock Option (Right to Buy)derivative
+8,000$0.00$08,000Feb 4, 2026
Jan 28, 2026William P. Quinn
President, CEO and CFO
AGrant or award
Employee Stock Option (Right to Buy)derivative
+20,000$0.00$020,000Feb 4, 2026
Dec 12, 2025Kathleen Laporte
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,392--1,392Dec 16, 2025
Dec 12, 2025Brian O'Callaghan
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,393--1,393Dec 16, 2025
Dec 12, 2025Laura Berner
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+2,500--2,500Dec 16, 2025
Dec 12, 2025Grant Yonehiro
Chief Operating Officer
AGrant or award
Employee Stock Option (Right to Buy)derivative
+3,214--3,214Dec 16, 2025
Dec 12, 2025Nicole Onetto
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,393--1,393Dec 16, 2025
Dec 12, 2025Sarah Nemec
Senior VP, Finance and PAO
AGrant or award
Employee Stock Option (Right to Buy)derivative
+1,236--1,236Dec 16, 2025
Dec 12, 2025Jakob Dupont
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+2,500--2,500Dec 16, 2025
Dec 12, 2025William P. Quinn
President, CEO and CFO
AGrant or award
Employee Stock Option (Right to Buy)derivative
+7,614--7,614Dec 16, 2025
Dec 12, 2025Kathleen Laporte
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,392--0Dec 16, 2025
Dec 12, 2025Sarah Nemec
Senior VP, Finance and PAO
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-1,236--0Dec 16, 2025
Dec 12, 2025Grant Yonehiro
Chief Operating Officer
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-3,214--0Dec 16, 2025
Dec 12, 2025Laura Berner
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-2,500--0Dec 16, 2025
Dec 12, 2025Brian O'Callaghan
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,393--0Dec 16, 2025
Dec 12, 2025Jakob Dupont
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-2,500--0Dec 16, 2025
Dec 12, 2025Nicole Onetto
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,393--0Dec 16, 2025
Dec 12, 2025William P. Quinn
President, CEO and CFO
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-7,614--0Dec 16, 2025
Dec 12, 2025William P. Quinn
President, CEO and CFO
AGrant or award
Employee Stock Option (Right to Buy)derivative
+3,927--3,927Dec 16, 2025
Dec 12, 2025Kathleen Laporte
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,250--1,250Dec 16, 2025
Dec 12, 2025Sarah Nemec
Senior VP, Finance and PAO
AGrant or award
Employee Stock Option (Right to Buy)derivative
+375--375Dec 16, 2025
Dec 12, 2025Jakob Dupont
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+849--849Dec 16, 2025
Dec 12, 2025Grant Yonehiro
Chief Operating Officer
AGrant or award
Employee Stock Option (Right to Buy)derivative
+660--660Dec 16, 2025
Dec 12, 2025Laura Berner
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+613--613Dec 16, 2025
Dec 12, 2025Nicole Onetto
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,107--1,107Dec 16, 2025
Dec 12, 2025Brian O'Callaghan
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,810--1,810Dec 16, 2025
Dec 12, 2025William P. Quinn
President, CEO and CFO
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-3,927--0Dec 16, 2025
Dec 12, 2025Sarah Nemec
Senior VP, Finance and PAO
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-375--0Dec 16, 2025
Dec 12, 2025Kathleen Laporte
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,250--0Dec 16, 2025
Dec 12, 2025Nicole Onetto
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,107--0Dec 16, 2025
Dec 12, 2025Brian O'Callaghan
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,810--0Dec 16, 2025
Dec 12, 2025Laura Berner
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-613--0Dec 16, 2025
Dec 12, 2025Grant Yonehiro
Chief Operating Officer
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-660--0Dec 16, 2025
Dec 12, 2025Jakob Dupont
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-849--0Dec 16, 2025
Dec 12, 2025William P. Quinn
President, CEO and CFO
AGrant or award
Employee Stock Option (Right to Buy)derivative
+5,000--5,000Dec 16, 2025
Dec 12, 2025Sarah Nemec
Senior VP, Finance and PAO
AGrant or award
Employee Stock Option (Right to Buy)derivative
+600--600Dec 16, 2025
Dec 12, 2025Kathleen Laporte
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,250--1,250Dec 16, 2025
Dec 12, 2025Brian O'Callaghan
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,250--1,250Dec 16, 2025
Dec 12, 2025Laura Berner
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,250--1,250Dec 16, 2025
Dec 12, 2025Nicole Onetto
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+611--611Dec 16, 2025
Dec 12, 2025Jakob Dupont
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,000--1,000Dec 16, 2025
Dec 12, 2025Grant Yonehiro
Chief Operating Officer
AGrant or award
Employee Stock Option (Right to Buy)derivative
+822--822Dec 16, 2025
Dec 12, 2025William P. Quinn
President, CEO and CFO
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-5,000--0Dec 16, 2025
Dec 12, 2025Sarah Nemec
Senior VP, Finance and PAO
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-600--0Dec 16, 2025
Dec 12, 2025Laura Berner
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,250--0Dec 16, 2025
Dec 12, 2025Kathleen Laporte
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,250--0Dec 16, 2025
Dec 12, 2025Brian O'Callaghan
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,250--0Dec 16, 2025
Dec 12, 2025Nicole Onetto
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-611--0Dec 16, 2025
Dec 12, 2025Jakob Dupont
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,000--0Dec 16, 2025
Dec 12, 2025Grant Yonehiro
Chief Operating Officer
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-822--0Dec 16, 2025
Dec 12, 2025William P. Quinn
President, CEO and CFO
AGrant or award
Employee Stock Option (Right to Buy)derivative
+10,499--10,499Dec 16, 2025
Dec 12, 2025Sarah Nemec
Senior VP, Finance and PAO
AGrant or award
Employee Stock Option (Right to Buy)derivative
+2,199--2,199Dec 16, 2025
Dec 12, 2025Nicole Onetto
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,250--1,250Dec 16, 2025
Dec 12, 2025Jakob Dupont
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,100--1,100Dec 16, 2025
Dec 12, 2025Kathleen Laporte
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,250--1,250Dec 16, 2025
Dec 12, 2025Brian O'Callaghan
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,250--1,250Dec 16, 2025
Dec 12, 2025Grant Yonehiro
Chief Operating Officer
AGrant or award
Employee Stock Option (Right to Buy)derivative
+1,653--1,653Dec 16, 2025
Dec 12, 2025Laura Berner
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,100--1,100Dec 16, 2025
Dec 12, 2025William P. Quinn
President, CEO and CFO
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-10,499--0Dec 16, 2025
Dec 12, 2025Sarah Nemec
Senior VP, Finance and PAO
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-2,199--0Dec 16, 2025
Dec 12, 2025Jakob Dupont
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,100--0Dec 16, 2025
Dec 12, 2025Brian O'Callaghan
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,250--0Dec 16, 2025
Dec 12, 2025Nicole Onetto
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,250--0Dec 16, 2025
Dec 12, 2025Grant Yonehiro
Chief Operating Officer
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-1,653--0Dec 16, 2025
Dec 12, 2025Laura Berner
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,100--0Dec 16, 2025
Dec 12, 2025Kathleen Laporte
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,250--0Dec 16, 2025
Dec 12, 2025William P. Quinn
President, CEO and CFO
AGrant or award
Employee Stock Option (Right to Buy)derivative
+12,499--12,499Dec 16, 2025
Dec 12, 2025Sarah Nemec
Senior VP, Finance and PAO
AGrant or award
Employee Stock Option (Right to Buy)derivative
+6,699--6,699Dec 16, 2025
Dec 12, 2025Kathleen Laporte
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,250--1,250Dec 16, 2025
Dec 12, 2025Brian O'Callaghan
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,100--1,100Dec 16, 2025
Dec 12, 2025Nicole Onetto
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,250--1,250Dec 16, 2025
Dec 12, 2025Grant Yonehiro
Chief Operating Officer
AGrant or award
Employee Stock Option (Right to Buy)derivative
+4,642--4,642Dec 16, 2025
Dec 12, 2025Laura Berner
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+1,100--1,100Dec 16, 2025
Dec 12, 2025William P. Quinn
President, CEO and CFO
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-12,499--0Dec 16, 2025
Dec 12, 2025Sarah Nemec
Senior VP, Finance and PAO
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-6,699--0Dec 16, 2025
Dec 12, 2025Kathleen Laporte
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,250--0Dec 16, 2025
Dec 12, 2025Brian O'Callaghan
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,100--0Dec 16, 2025
Dec 12, 2025Nicole Onetto
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,250--0Dec 16, 2025
Dec 12, 2025Grant Yonehiro
Chief Operating Officer
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-4,642--0Dec 16, 2025
Dec 12, 2025Laura Berner
director
DDisposition to issuer
Director Stock Option (Right to Buy)derivative
-1,100--0Dec 16, 2025
Dec 12, 2025Sarah Nemec
Senior VP, Finance and PAO
AGrant or award
Employee Stock Option (Right to Buy)derivative
+1,589--1,589Dec 16, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

BOLT insider trading: Bolt Biotherapeutics, Inc. | InsiderTell